相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics
Hady Ghanem et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management
Elihu H. Estey
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
Joannah Score et al.
BLOOD (2012)
Deletion of the tumor-suppressor gene NF1 occurs in 5% of myeloid malignancies and is accompanied by a mutation in the remaining allele in half of the cases
C. Haferlach et al.
LEUKEMIA (2012)
Impact of post-remission therapy in patients aged 65-70 years with de novo acute myeloid leukemia: a comparison of two concomitant randomized ALFA trials with overlapping age inclusion criteria
Raphael Itzykson et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia
W-C Chou et al.
LEUKEMIA (2011)
The inv(3)(q21q26)/t(3;3)(q21;q26) is frequently accompanied by alterations of the RUNX1, KRAS and NRAS and NF1 genes and mediates adverse prognosis both in MDS and in AML: a study in 39 cases of MDS or AML
C. Haferlach et al.
LEUKEMIA (2011)
Comparison of Three Targeted Enrichment Strategies on the SOLiD Sequencing Platform
Dale J. Hedges et al.
PLOS ONE (2011)
Which AML Subsets Benefit From Leukemic Cell Priming During Chemotherapy? Long-Term Analysis of the ALFA-9802 GM-CSF Study
Xavier Thomas et al.
CANCER (2010)
NF1 Inactivation in Adult Acute Myelogenous Leukemia
Brian Parkin et al.
CLINICAL CANCER RESEARCH (2010)
Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1
Doris Steinemann et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
High-resolution single-nucleotide polymorphism array-profiling in myeloproliferative neoplasms identifies novel genomic aberrations
Frank Stegelmann et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Randomized Study of Intensified Anthracycline Doses for Induction and Recombinant Interleukin-2 for Maintenance in Patients With Acute Myeloid Leukemia Age 50 to 70 Years: Results of the ALFA-9801 Study
Cecile Pautas et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
AML with CBFB-MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletions
C. Haferlach et al.
LEUKEMIA (2010)
Waved aCGH: to smooth or not to smooth
F. Lepretre et al.
NUCLEIC ACIDS RESEARCH (2010)
Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype
Tadayuki Akagi et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Acquired copy number alterations in adult acute myeloid leukemia genomes
Matthew J. Walter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis
Brian V. Balgobind et al.
BLOOD (2008)
Monosomal karyotype in acute myeloid leukemia:: A better indicator of poor prognosis than a complex karyotype
Dimitri A. Breems et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cooperating gene mutations in acute myeloid leukemia: a review of the literature
A. Renneville et al.
LEUKEMIA (2008)
Neurofibromatosis 1, and not TP53, seems to be the main target of chromosome 17 deletions in de novo acute myeloid leukemia
Javier Suela et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization
Frank G. Ruecker et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
分享论文
